Therefore, we suggest that U-PDE9A levels and UI are effective markers for use in non-invasive prenatal detection of DS during the first trimester regardless of fetal gender, and in fact, these markers may detect fetal DS more effectively than current screening tests for fetal DS. Here, PDE9A is linked to Dravet syndrome.